Objective To evaluate the cardotoxicity from recombinant human endostatin (rh-endostatin)
combined with chemotherapy. Methods A total of 12 cancer patients treated with …

Objective To evaluate the value of the myocardial biochemical markers including creatine
kinase MB isoenzyme (CK-MB), cardiac isoform of Tropnin-T (cTnT) and N-termimal pro …

Sir d A 72-year-old female patient with stage IV adenocarcinoma of the lung was treated with
recombinant human endostatin (rh-endostatin) combined with gemcitabine. The patient …

Objective: This study aimed to investigate the tolerance and pharmacokinetic characteristics
of recombinant human endostatin (rh-endostatin) administered as single-dose or multiple …

Purpose Studies indicate that recombinant human endostatin (rh-endostatin) can inhibit
tumor endothelial cell proliferation, angiogenesis, and tumor growth. This study assessed …

Objective: To investigate the short-term efficacy and safety of recombinant human endostatin
YH-16 combined with navelbine and cisplatin in the first line treatment of advanced non …

To explore the efficacy and safety of human recombinant endostatin (rh-endostatin) plus
pemetrexed and cisplatin in the treatment of advanced non-small cell lung cancer (NSCLC) …

目的 观察重组人血管内皮抑制素 (YH-16) 联合 NP 方案 (去甲长春花碱 NVB+ 顺铂 DDP)
治疗晚期非小细胞肺癌的疗效和安全性, 并与 NP 方案比较. 方法 18 例 ⅢB~ Ⅳ 期 NSCLC …

Abstract Objective Recombinant human Endostatin (rh-Endostatin, YH-16) can reverse
cisplatin resistance in A549/DDP cells. However, the possible effect of rh-Endostatin in …

7138 Background: Endostar (rh-endostatin, YH-16) is a new recombinant human endostatin
developed by Medgenn Co. Ltd. Pre-clinical study indicates that it can inhibit tumor …